1166831-45-3 Usage
General Description
Methyl 6-chloro-3-methylpyrazine-2-carboxylate is an organic compound with a chemical formula of C7H7ClN2O2. This chemical belongs to the class of organic compounds known as pyrazines, which are polycyclic aromatic compounds containing a pyrazine ring, a six-membered aromatic heterocycle, made up of two nitrogen atoms and four carbon atoms. The molecular weight of the compound is 188.59 g/mol. The physical and chemical properties of this particular compound, such as melting point, boiling point, and solubility, can vary based on the conditions under which it is studied or used. While its biological activities and uses are not primarily discussed in literature, other pyrazine derivatives have found applications in pharmaceuticals, agrochemicals, and food industry. As with all chemicals, appropriate safety measures should be adopted while handling or using Methyl 6-chloro-3-methylpyrazine-2-carboxylate.
Check Digit Verification of cas no
The CAS Registry Mumber 1166831-45-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,6,6,8,3 and 1 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1166831-45:
(9*1)+(8*1)+(7*6)+(6*6)+(5*8)+(4*3)+(3*1)+(2*4)+(1*5)=163
163 % 10 = 3
So 1166831-45-3 is a valid CAS Registry Number.
1166831-45-3Relevant articles and documents
ISOXAZOLINE DERIVATIVES AS PESTICIDES
-
Page/Page column 101, (2021/06/26)
The present invention provides compounds of formula (I): which are useful for long-lasting treatment and control of pests, for example fleas and ticks, in companion animals and livestock, and pharmaceutical compositions and methods of using the same.
INDAZOLES AND AZAINDAZOLES AS LRRK2 INHIBITORS
-
, (2021/01/29)
The present invention is directed to indazole and azaindazole compounds which are inhibitors of LRRK2 and are useful in the treatment of CNS disorders.
PYRAZINE CARBAMATES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS
-
, (2020/12/25)
Pyridine carbamates, pharmaceutical compositions containing pyridine carbamates, and uses of the pyridine carbamates and pharmaceutical compositions for modulating GluN2B receptors and for treating diseases, disorders, and medical conditions mediated by GluN2B receptor activity.